Abstract

Germ cell tumors of the testis are relatively rare carcinomas, comprising only 1% of all tumors in men.

However, because it represents a tumor with a high cure rate, affects young individuals in full productive age and is a model of disease curable even in advanced stages, with chemotherapy, it is extremely important to recognize it and increase all efforts in basic and clinical research, to improve not only the already high proportion of cured patients, but also to reduce the toxicity of the treatments.

Keywords: Germ Cell Tumors; Testicular Cancer; Chemotherapy

References

1. Einhorn LH. "Testicular cancer: a model for a curable neoplasm". Cancer Research 41 (1981): 3275-3280.
2. Einhorn LH. “Treatment of testicular cancer: a new and improved model”. Journal of Clinical Oncology 8 (1990): 1777-1781.
3. Whitmore WF. “Surgical treatment of adult germinal testis tumors”. Seminar on Oncology 6 (1979): 55-68.
4. Donohue JP., et al. “Distribution of nodal metastases in non-seminomatous testi cancer”. Journal of Urology 128 (1982): 315-320.
5. Kirkwood JM., et al. “Current Cancer therapeutics”. First edition Current medicine (1994).
6. Stutzman RE and Mc Leod DG. “Radiation therapy: a primary treatment modality for seminoma”. Urologic Clinics of North America 3 (1980): 757-764.
7. Duchesne GM., et al. “Orchidectomy alone for stage I seminoma of the testis”. Cancer 5 (1990): 1115-1118.
8. Gospodarwicz MK., et al. “Early stage and advanced seminoma: role of radiation therapy, surgery and chemotherapy”. Seminar on Oncology2 (1998): 160-173.
9. Sujka SK and Huben RP. “Clinical stage I nonseminomatous germ cell tumors of the testis. Observation vs retroperitoneal lymph node dissection ”. Urology 1 (1991): 29-31.
10. Friedman EL., et al. “Therapeutic guidelines and results in advanced seminoma”. Journal of Clinical Oncology10 (1985): 1325-1332.
11. Ball D., et al. “The management of metastatic seminoma testis”. Cancer11 (1982): 2289-2294.
12. Williams SD., et al. “Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide”. The New England Journal of Medicine 23 (1987): 1435-1440.
13. Einhorn LH., et al. “Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction”. Cancer 4 (1981): 904-908.
14. Murphy BR., et al. “Surgical salvage of chemorefractory germ cell tumors”. Journal of Clinical Oncology2 (1993): 324-329.
15. De Vita VT., et al. “Cancer: priniciples and practice of Oncology”. 6th ed. Philadelphia, Pa: Lippincott Williams andWilkins (2001).
16. Socinski MA and Stomper PC. “Radiologic evaluation of nonseminomatous germ cell tumor of the testis”. Seminar on Urology3 (1988): 203-215.
17. Murphy GP., et al. “Clinical Oncology”. Manual of the American Cancer Society. Second edition. Pan American Health Organization (1996).
18. Kein EA. “Tumor markers in testis cancer". Urologic Clinics of North America 20 (1993): 67-73.
19. Raghavan D. “Testicular carcinoma”. In: Johnson F.E., Virgo K.S., eds. Cancer patient follow-up. St Louis: Mosby (1997): 408-431.
20. Kelty P., et al. “Germ cell testis cancer: 15-year review”. Journal of Surgical Oncology 62 (1996): 30-33.

Citation

Citation: Adrian P Hunis. “Testicular Cancer: Update Your Diagnosis, Prognosis, and Treatment”. Acta Scientific Cancer Biology 5.11 (2021): .

Copyright

Copyright: © 2021 Adrian P Hunis. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.